[56B2-56B2];[56C8-56C8];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
56B2;56C8
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
The presence of P+PBac{XP5.RB3}BSC349 was verified using the PCR methods and primers described in FBrf0175003 with the substitution of the primer
5'-CCAATGCGTTTATTTCAGGTCACG-3' for the RB3' plus or RB3' minus primer.
The cytological breakpoints of Df(2R)BSC349 predicted from the Release 5 genomic coordinates of the P{XP}d01394 and PBac{RB}CG18606e04639 transposable element insertions sites are 56B2;56C8.